154 related articles for article (PubMed ID: 16532331)
1. Update on management of infections in cancer and stem cell transplant patients.
Neuburger S; Maschmeyer G
Ann Hematol; 2006 Jun; 85(6):345-56. PubMed ID: 16532331
[TBL] [Abstract][Full Text] [Related]
2. Clinical guidelines for the management of neutropenic patients with unexplained fever in Japan: validation by the Japan Febrile Neutropenia Study Group.
Tamura K
Int J Antimicrob Agents; 2005 Dec; 26 Suppl 2():S123-7; discussion S133-40. PubMed ID: 16249072
[TBL] [Abstract][Full Text] [Related]
3. Chemotherapy of infections in cancer patients: a review.
Sim SK
Am J Hosp Pharm; 1975 Jan; 32(1):35-44. PubMed ID: 1092159
[TBL] [Abstract][Full Text] [Related]
4. Infectious complications after allogeneic stem cell transplantation: incidence in matched-related and matched-unrelated transplant settings.
Rieger CT; Rieger H; Kolb HJ; Peterson L; Huppmann S; Fiegl M; Ostermann H
Transpl Infect Dis; 2009 Jun; 11(3):220-6. PubMed ID: 19298239
[TBL] [Abstract][Full Text] [Related]
5. Fever of unknown origin in febrile leukopenia.
Antoniadou A; Giamarellou H
Infect Dis Clin North Am; 2007 Dec; 21(4):1055-90, x. PubMed ID: 18061089
[TBL] [Abstract][Full Text] [Related]
6. Febrile neutropenia in paediatric peripheral blood stem cell transplantation, in -vitro sensitivity data and clinical response to empirical antibiotic therapy.
Ansari SH; Nasim S; Ahmed A; Irfan M; Ishaque A; Farzana T; Panjwani VK; Taj M; Shamsi TS
J Coll Physicians Surg Pak; 2006 Nov; 16(11):704-8. PubMed ID: 17052420
[TBL] [Abstract][Full Text] [Related]
7. Microbiologic consequences of new approaches to managing hematologic malignancies.
Blijlevens NM; Donnelly JP; de Pauw BE
Rev Clin Exp Hematol; 2005 Dec; 9(2):E2. PubMed ID: 16864116
[TBL] [Abstract][Full Text] [Related]
8. Prophylaxis and treatment of bacterial infections: do we need new strategies?
Micozzi A; Bucaneve G
Rev Clin Exp Hematol; 2005 Dec; 9(2):E4. PubMed ID: 16864118
[TBL] [Abstract][Full Text] [Related]
9. Supportive care for viral infections in cancer patients.
Gallagher J
Curr Opin Oncol; 1991 Aug; 3(4):643-7. PubMed ID: 1932222
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis and antimicrobial therapy of lung infiltrates in febrile neutropenic patients: Guidelines of the infectious diseases working party of the German Society of Haematology and Oncology.
Maschmeyer G; Beinert T; Buchheidt D; Cornely OA; Einsele H; Heinz W; Heussel CP; Kahl C; Kiehl M; Lorenz J; Hof H; Mattiuzzi G
Eur J Cancer; 2009 Sep; 45(14):2462-72. PubMed ID: 19467584
[TBL] [Abstract][Full Text] [Related]
11. Comparison of antigenemia assay and semiquantitative polymerase chain reaction test for monitoring active cytomegalovirus infection in allogeneic hematopoietic cell transplant recipients.
Pajand O; Ziyaeyan M; Mousavi S; Fatolahzadeh B; Hojabri Z; Bahador A; Abdossamadi Z
Exp Clin Transplant; 2008 Jun; 6(2):149-54. PubMed ID: 18816243
[TBL] [Abstract][Full Text] [Related]
12. A pilot phase II study of alternate day ganciclovir and foscarnet in preventing cytomegalovirus (CMV) infections in at-risk pediatric and adolescent allogeneic stem cell transplant recipients.
Shereck EB; Cooney E; van de Ven C; Della-Lotta P; Cairo MS
Pediatr Blood Cancer; 2007 Sep; 49(3):306-12. PubMed ID: 16972242
[TBL] [Abstract][Full Text] [Related]
13. [Infection in neutropenic cancer patients--etiology, microbiological diagnostics, treatment].
Durnaá B; Dzierzanowska D
Wiad Lek; 2006; 59(7-8):506-11. PubMed ID: 17209349
[TBL] [Abstract][Full Text] [Related]
14. [Intraabdominal and hepatic infections in pediatric cancer patients].
Ballauff A; Eggert A
Klin Padiatr; 2005 Nov; 217 Suppl 1():S101-9. PubMed ID: 16288356
[TBL] [Abstract][Full Text] [Related]
15. New antimicrobial agents for the treatment of bacterial infections in cancer patients.
Rolston KV
Hematol Oncol; 2009 Sep; 27(3):107-14. PubMed ID: 19569253
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of ganciclovir against human herpesvirus-6 excreted in saliva in stem cell transplant recipients.
Ljungman P; Dahl H; Xu YH; Larsson K; Brytting M; Linde A
Bone Marrow Transplant; 2007 Apr; 39(8):497-9. PubMed ID: 17334385
[TBL] [Abstract][Full Text] [Related]
17. The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Fever and neutropenia: the early years.
Bodey GP
J Antimicrob Chemother; 2009 May; 63 Suppl 1():i3-13. PubMed ID: 19372179
[TBL] [Abstract][Full Text] [Related]
18. The clinical impact of antibacterial prophylaxis and cycling antibiotics for febrile neutropenia in a hematological malignancy and transplantation unit.
Craig M; Cumpston AD; Hobbs GR; Devetten MP; Sarwari AR; Ericson SG
Bone Marrow Transplant; 2007 Apr; 39(8):477-82. PubMed ID: 17322937
[TBL] [Abstract][Full Text] [Related]
19. Severe infections after unrelated donor allogeneic hematopoietic stem cell transplantation in adults: comparison of cord blood transplantation with peripheral blood and bone marrow transplantation.
Parody R; Martino R; Rovira M; Vazquez L; Vázquez MJ; de la Cámara R; Blazquez C; Fernández-Avilés F; Carreras E; Salavert M; Jarque I; Martín C; Martínez F; López J; Torres A; Sierra J; Sanz GF;
Biol Blood Marrow Transplant; 2006 Jul; 12(7):734-48. PubMed ID: 16785063
[TBL] [Abstract][Full Text] [Related]
20. Prevention and early treatment of invasive fungal infection in patients with cancer and neutropenia and in stem cell transplant recipients in the era of newer broad-spectrum antifungal agents and diagnostic adjuncts.
Segal BH; Almyroudis NG; Battiwalla M; Herbrecht R; Perfect JR; Walsh TJ; Wingard JR
Clin Infect Dis; 2007 Feb; 44(3):402-9. PubMed ID: 17205448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
